• Home
  • NEW DAY MEDICINE
  • 4 (78) 2025
  • 167 -4 (78) 2025 - Bekmetova F.M., Usmonova N.A. - ACUTE MYOCARDIAL INFARCTION IN YOUNG PEOPLE: EPIDEMIOLOGY, RISK FACTORS, AND PREVENTION METH

167 -4 (78) 2025 - Bekmetova F.M., Usmonova N.A. - ACUTE MYOCARDIAL INFARCTION IN YOUNG PEOPLE: EPIDEMIOLOGY, RISK FACTORS, AND PREVENTION METH

ACUTE MYOCARDIAL INFARCTION IN YOUNG PEOPLE: EPIDEMIOLOGY, RISK FACTORS, AND PREVENTION METHODS

Bekmetova F.M. - Republican Specialized Scientific and Practical Medical Center of Cardiology Uzbekistan

Usmonova N.A. - Republican Specialized Scientific and Practical Medical Center of Cardiology Uzbekistan

Mukhamedova M.G. - Republican Specialized Scientific and Practical Medical Center of Cardiology Uzbekistan

Tursunova N.B. - Republican Specialized Scientific and Practical Medical Center of Cardiology Uzbekistan

Abdullaeva S.Y. - Republican Specialized Scientific and Practical Medical Center of Cardiology Uzbekistan

Valieva B.Sh. - Republican Specialized Scientific and Practical Medical Center of Cardiology Uzbekistan

Donyorov Sh.N. - Republican Specialized Scientific and Practical Medical Center of Cardiology Uzbekistan

Khotamova M.N. - Republican Specialized Scientific and Practical Medical Center of Cardiology Uzbekistan

Karimov B.S. - Republican Specialized Scientific and Practical Medical Center of Cardiology Uzbekistan

Resume

Acute myocardial infarction (AMI) among young people is increasing, which is associated with both traditional (dyslipidemia, hypertension, diabetes, obesity, smoking, stress) and non-traditional risk factors (energy drinks, e-cigarettes, circadian rhythm disorders). Women in younger age groups have a higher risk of adverse outcomes. Prevention requires a comprehensive approach, including lifestyle modifications (lipid control, normalizing blood pressure and body weight, quitting smoking), as well as considering the patient's emotional state and normalizing sleep.

Keywords: acute myocardial infarction in young people, epidemiology, risk factors, prevention methods

First page

939

Last page

944

For citation:Bekmetova F.M., Usmonova N.A., Mukhamedova M.G., Tursunova N.B., Abdullaeva S.Y., Valieva B.Sh., Donyorov Sh.N., Khotamova M.N., Karimov B.S. - ACUTE MYOCARDIAL INFARCTION IN YOUNG PEOPLE: EPIDEMIOLOGY, RISK FACTORS, AND PREVENTION METHODS//New Day in Medicine 4(78)2025 939-944 https://newdayworldmedicine.com/en/new_day_medicine/4-78-2025

List of References

  1. Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232-3245.
  2. Townsend N, Nichols M, Scarborough P, Rayner M. Cardiovascular disease in Europe - epidemiological update 2015. Eur Heart J. 2015;36(40):2696-2705.
  3. Khan NA, Daskalopoulou SS, Karp I, et al. Sex differences in acute coronary syndrome symptom presentation in young patients. JAMA Intern Med. 2013;173(20):1863-1871.
  4. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-952.
  5. Prospective Studies Collaboration, Lewington S, Whitlock G, et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007;370(9602):1829-1839.
  6. Chambless LE, Folsom AR, Sharrett AR, et al. Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol. 2003;56(9):880-890.
  7. Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215-2222.
  8. de Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J. 2007;28(7):850-856.
  9. Asia Pacific Cohort Studies Collaboration. Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol. 2005;34(5):1036-1045.
  10. Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease. Eur Heart J. 2013;34(45):3478-3490a.
  11. Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab. 2012;97(11):3956-3964.
  12. Khera AV, Emdin CA, Drake I, et al. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. N Engl J Med. 2016;375(24):2349-2358.
  13. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459-2472.
  14. CARDIoGRAMplusC4D Consortium, Deloukas P, Kanoni S, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45(1):25-33.
  15. Hollan I, Meroni PL, Ahearn JM, et al. Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev. 2013;12(10):1004-1015.
  16. Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012;71(9):1524-1529.
  17. Fardet L, Petersen I, Nazareth I. Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study. BMJ. 2012;345:e4928.
  18. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum. 1999;42(2):338-346.
  19. Rizos CV, Elisaf MS. Patient with acute coronary syndrome and high cardiovascular risk: therapeutic options. World J Cardiol. 2014;6(6):209-217.
  20. Monarca C, Rizzo MA, Adami G, et al. The Impact of Biologics and Glucocorticoids on Cardiovascular Disease in Rheumatoid Arthritis. Medicina (Kaunas). 2021;57(11):1243.

    file

    download